Advertisement SGS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More




SGS is a life science, global contract service organisation, providing integrated services companies with integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and quality control testing.

With over 2,000 trials performed and more than 40 years of experience, we serve the pharmaceutical, biotechnology and medical device industries.

Our state-of-the-art facilities include a clinical pharmacology task force of three hospital embedded units, three bioanalytical labs and clinical trial management offices across Europe (including CEE) and North America for global Phase I-IV trial coordination.

With experience in clinical pharmacology and regulatory intelligence, innovative study designs, high-quality facilities, and customised biometrics services, we can significantly improve clients’ drug development timelines and decision-making processes.

Early development

As one of the largest European early development CROs, SGS offers a complete range of services, including:

Clinical pharmacology

SGS is experienced in performing complex trials in healthy volunteers and patients, such as:

  • First In Human trials: Single Ascending, Dose (SAD) and Multiple Ascending, Dose (MAD), combined protocols: SAD/MAD + food + POC
  • Regulatory Phase I trials: Drug-drug interactions, Pivotal TQTc prolongation trials, PK and PD studies, BA/BE studies
  • Exploratory Early phase trials: Early POC studies in patients, 14 C radio-labelled ADME studies, Biomarkers for clinical trials, Viral Challenge testing
  • A large scope of biomarkers and clinical pharmacodynamic models

With 88 hospitalisation beds, including 20 unique quarantine beds (Biosafety Level 2Q), the SGS clinical unit in Antwerp, Belgium, has successfully passed several US FDA inspections. Clients benefit from the favourable regulatory environment with short phase I trial approval times of two weeks, as well as a large database of more than 10,000 volunteers and special population subjects.

For complex early phase patient clinical trials, SGS has established a network of in-patient clinical pharmacology units in hospitals in Belgium and Hungary.

Pre-clinical and bioanalytical capabilities

With its GLP-certified bioanalytical laboratory network, SGS has an international reputation for assay of drugs in biological fluids, as well as complex method development and validation.

Late development

SGS is organised as a full CRO to deliver phase II-IV research services on-time and on-budget with a high-quality network of experts and sites, ensuring fast recruitment and site activation. Whether you request a comprehensive service package or are interested in individually selected services, SGS can meet your requirements.

Phase II-IV trial management

Trained in the latest international guidelines and company SOPs, our team of more than 100 individuals has conducted over 800 projects, including trials with patients in Europe, Russia, and North America.

For high-quality clinical trial execution, we offer:

  • Proven therapeutic expertise with a focus in infectious, cardiac and neurological diseases
  • Centralised project management with multilingual senior project managers
  • Efficient project management tools such as CTMS, IVRS, central ECG reading, and EDC
  • Large database of investigators and key opinion leaders
  • Site Management Organization (SMO), managing a network of clinical sites and hospitals for an array of disease areas

Clinical support services

Drug development consultancy and services

As a standalone service, SGS assists in the development of molecules in early clinical phases by bringing impartial advice and solutions on development plans.

Our dedicated multi-disciplinary team can assess projects and offer guidance to clients on how to reach a conclusion more safely and quickly.

Data management/statistics and medical writing

As one of the largest independent data management teams in Europe, SGS supports all in-house and external project needs for clients’ clinical trials, powered with Oracle Inform®, Merge sClinicalOS® and Medidata Rave®.

Our knowledgeable, proactive staff collaborate with various EDC systems and e-CRF templates. SGS is CDISC compliant and experienced in full electronic FDA submissions.

Regulatory and medical affairs

The Regulatory Affairs department provides consultancy services in both European and US registration of biotech and prescription drugs, veterinary products and medical devices with comprehensive EMEA and FDA authority expertise.

The Medical Affairs department provides full phase I-IV pharmacovigilance services such as Serious Adverse Event (SAE) handling, set-up and management of in-house safety database (Oracle Argus Safety), ADR reports, medical review and narrative medical writing, electronic reporting in Europe to Eudravigilance and health authorities.

Contact Us

SGS Life Sciences on LinkedIn:
SGS Case Study – ADHD Study Phase III Challenges on YouTube
SGS Case Study – Phase III Studies in Hypoglycemic Type I Diabetic Participants on YouTube
The SGS CPU is Moving on YouTube

Quick Contact SGS

Top Products from SGS

Quick Contact SGS
Quick Contact SGS

SGS Advances Clinical Trial Data Management with Veeva Vault EDC

SGS adopts Veeva Vault EDC to improve site data capture and quality for faster study cycle times during clinical trials.
14th June 2022

SGS Facilitates Selecta Biosciences and Askbio’s FIH Study to Evaluate Immtor™ in Gene Therapy

SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical (AskBio) Phase 1 dose-escalation trial of SEL-399,...
30th March 2021

SGS Increases its Capacity for Human Challenge Studies

SGS will move its Clinical Pharmacology Unit (CPU) to a new location in 2021, increasing its capacity to conduct Human...
18th November 2020

SGS Welcomes First Participants Onto Covid-19 Clinical Trials in US

SGS is pleased to announce the recruitment of the first participants in the US who will be taking part in...
10th November 2020

SGS Wins ‘Highly Commended’ Award in the 2020 Vaccine Industry Excellence Awards

SGS is celebrating after winning the ‘Highly Commended’ award for ‘Best Contract Research Organization’ in the finals of the 2020...
21st October 2020

SGS Donates PPE and Offers Beds and Staff to ZNA Stuivenberg Hospital, Antwerp, Belgium

SGS is supporting ZNA Stuivenberg Hospital, Antwerp in its fight against the COVID-19 pandemic.
16th April 2020

SGS Digicomply Launches COVID-19 INTEL – an AI Platform for Teams on the Pandemic Research Frontline

As medical research teams around the world accelerate their efforts to combat the COVID-19 pandemic, SGS Digicomply has launched a...
8th April 2020

SGS 2019 Full Year Results

SGS delivers solid results and makes significant strategic progress in 2019, which will strengthen the Group’s market leadership position in...
28th January 2020
Quick Contact SGS

The SGS CPU is Moving

Published on March 30, 2021
Quick Contact SGS

Appropriate and reliable data required for conclusive FIH/Phase 1 trials

Clinical trials are intended to find answers to a research question by generating data to prove or disprove a hypothesis.
11th February 2020

Ensuring inspection readiness at clinical facilities

The principles of Good Clinical Practice (GCP) serve to ensure the protection of trial participants and the integrity of the...
11th February 2020

Consider modelling and simulation studies in early phase clinical trials

Improving experimental drug success rate and accelerating clinical development are top priorities for pharmaceutical and biotech companies.
11th February 2020
Quick Contact SGS
Quick Contact SGS

Contact SGS

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact SGS